Sanofi News Headlines

SNY 
$46.2736
*  
0.0764
0.16%
Get SNY Alerts
*Delayed - data as of Dec. 26, 2014 10:00 ET  -  Find a broker to begin trading SNY now
Exchange: NYSE
Industry: Health Care
Community Rating:
View:    SNY Real Time
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
Sanofi Bolsters Vaccine Business
8/18/2014 8:39:00 AM - Seeking Alpha


Week In Review: ZAI Lab In-Licenses 2 Sanofi Drug Candidates
8/17/2014 8:03:00 AM - Seeking Alpha


Tracking Warren Buffett's Berkshire Hathaway Portfolio - Q2 2014 Update
8/16/2014 5:19:00 AM - Seeking Alpha


Ebola Vaccine and Inhaled Insulin Incoming
8/16/2014 5:01:02 AM - Motley Fool


Merck's Insomnia Drug Belsomra Approved by the FDA - Analyst Blog
8/14/2014 4:00:00 PM - Zacks.com


Stock Market News for August 14, 2014 - Market News
8/14/2014 9:10:00 AM - Zacks.com


5 Things MannKind Corp.'s Management Wants You to Know
8/13/2014 5:30:55 PM - Motley Fool


Properly Treating Costs: Re-Evaluating The MannKind And Sanofi Partnership
8/13/2014 4:53:00 PM - Seeking Alpha


Update: MannKind Q2 Earnings - Stock Sent To The Woodshed
8/13/2014 10:14:00 AM - Seeking Alpha


3 Great Value Stocks For A Secure Retirement
8/13/2014 7:00:00 AM - Investopedia


Cramer's Mad Money - These 2 Sectors Have A Huge Void (8/12/14)
8/13/2014 6:09:00 AM - Seeking Alpha


Why all the action is now in biotech
8/12/2014 11:17:00 AM - Market Intelligence Center


MannKind Posts Wider Q2 Loss, Up on Sanofi Deal for Afrezza - Analyst Blog
8/12/2014 10:05:00 AM - Zacks.com


MannKind Corporation Stock Signs Up Sanofi, Investors Conflicted
8/12/2014 6:00:03 AM - Motley Fool


Synta Pharmaceuticals: The Data Justify A Much Higher Share Price
8/11/2014 5:05:00 PM - Seeking Alpha


MannKind Enters into a Global Deal with Sanofi for Afrezza - Analyst Blog
8/11/2014 4:20:00 PM - Zacks.com


Closing Update: Stocks Firm, Pare Gains as NATO Questions Russian Aid Overtures to Revive Geopolitical Concern
8/11/2014 3:17:53 PM - MT Newswires


Update: Merrimack Earnings - Looming Concerns Still Remain
8/11/2014 2:04:00 PM - Seeking Alpha


Why The Sanofi Deal Is The Best Possible Deal For MannKind Investors
8/11/2014 1:09:00 PM - Seeking Alpha


Sector Update: Health Care Stocks Log Narrow Advance; MannKind Inks Pact for Inhaled Insulin
8/11/2014 12:23:22 PM - MT Newswires


Sector Update: Health Care
8/11/2014 12:18:42 PM - MT Newswires


Midday Update: Stocks Capitalize on Geo-Political Calm, Dovish Fed Comments
8/11/2014 11:24:42 AM - MT Newswires


Update: MannKind Enters Licensing Agreement - Is The Giant Leap Now Made Possible?
8/11/2014 10:43:00 AM - Seeking Alpha


Sanofi Appears To Be In The Early Stages Of An Earnings Rebound
8/11/2014 9:56:00 AM - Seeking Alpha


U.S. Stock Futures Bolstered by Easing Geopolitical Pressures, Dovish Comments From Fed's Fischer
8/11/2014 8:28:24 AM - MT Newswires